newborn screening program
Arizona modifies newborn screening requirements to alter disease detection protocols and procedures for testing infants for genetic and metabolic disorders.
Arizona modifies newborn screening requirements to alter disease detection protocols and procedures for testing infants for genetic and metabolic disorders.
SB 1344 modifies Arizona's newborn screening program, which tests infants for serious genetic, metabolic, and functional disorders shortly after birth. The bill adjusts screening requirements, procedures, or the panel of conditions tested, though specific substantive changes require review of the bill text itself.
Newborn screening programs are critical public health infrastructure—early detection of conditions like sickle cell disease, cystic fibrosis, or metabolic disorders enables immediate treatment that prevents severe disability or death. Changes to screening protocols directly affect which conditions are caught early and how families access results and follow-up care.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.